Jim Kastenmayer Steps Down as General Counsel of Aeglea BioTherapeutics

Jim Kastenmayer left the role of General Counsel at Aeglea BioTherapeutics on May 16, 2023, according to an SEC filing.

Aeglea BioTherapeutics disclosed that the employment of its general counsel, Jim Kastenmayer, was terminated effective May 16, 2023, along with that of its president and chief executive officer. (Source: an SEC filing.)

More legal leadership moves at Aeglea BioTherapeutics

• Heidy Abreu King-Jones Named Chief Legal Officer and Corporate Secretary of Aeglea BioTherapeutics (September 5, 2023)
• Jim Kastenmayer Named General Counsel of Aeglea BioTherapeutics (July 26, 2021)

Other general counsel moves in May 2023

• Jas S. Hayes Named Executive Vice President, General Counsel and Corporate Secretary of JELD-WEN Holding (May 31, 2023)
• Adam Veness Steps Down as General Counsel and Secretary of Cyteir Therapeutics (May 30, 2023)
• Kyle Guse Steps Down as General Counsel and Chief Financial Officer of Atossa Therapeutics (May 26, 2023)
• Monica Thomas Named General Counsel of G1 Therapeutics (May 25, 2023)
• Megan Yung Named General Counsel of Eterna Therapeutics (May 25, 2023)
• Chuck Cassidy Named General Counsel of BigCommerce (May 24, 2023)
• Jeff Mengoli Steps Down as Chief Legal Officer of BigCommerce (May 24, 2023)
• Joanna M. Totsky Steps Down as Senior Vice President, Chief Legal and Transformation Officer and Secretary of Cooper-Standard Holdings (May 23, 2023)

Browse every appointment in the General Counsel Directory.

Source: an SEC filing. InhouseBlog summarizes publicly reported general counsel moves and links to the original report.

Does this information need updating? Email us at info@inhouseblog.com.